ANDA 86808, held by Chartwell Rx. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 86808 (Cyproheptadine Hydrochloride), held by Chartwell Rx, was first approved by FDA on Feb 24, 1981, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 24, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride4MG ยท tablet;oral | Cyproheptadine Hydrochloride | Discontinued |
| Jun 20, 1983 | Supplement 10Manufacturing | Approved | None posted |
| Jun 14, 1983 | Supplement 9Manufacturing | Approved | None posted |
| Dec 7, 1982 | Supplement 8Manufacturing | Approved | None posted |
| Jul 6, 1982 | Supplement 6Manufacturing | Approved | None posted |
| Feb 24, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters